Epidemiological trends indicate a decline in RHD prevalence in high-income countries due to improved healthcare access, better living conditions, and widespread use of antibiotics. However, the disease remains endemic in many low- and middle-income countries, where it continues to be a significant cause of morbidity and mortality among children and young adults.
